Most studies assessed humoral responses by estimating anti-S1 or anti-RBD IgG or IgM as a surrogate for nAbs; however, these antibodies might indicate past or recent exposure to COVID-19, rather than neutralizing ability. Here, CD40LG is linked to COVID-19.